Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 887

1.

Ubrogepant for the Treatment of Migraine.

Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A.

N Engl J Med. 2019 Dec 5;381(23):2230-2241. doi: 10.1056/NEJMoa1813049.

PMID:
31800988
2.

The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings.

Tepper SJ, Silberstein SD, Rosen NL, Lipton RB, Dennehy EB, Dowsett SA, Doty E.

Headache. 2019 Dec 2. doi: 10.1111/head.13716. [Epub ahead of print]

PMID:
31792964
3.

Prevalence and correlates of mild cognitive impairment among diverse Hispanics/Latinos: Study of Latinos-Investigation of Neurocognitive Aging results.

González HM, Tarraf W, Schneiderman N, Fornage M, Vásquez PM, Zeng D, Youngblood M, Gallo LC, Daviglus ML, Lipton RB, Kaplan R, Ramos AR, Lamar M, Thomas S, Chai A, DeCarli C.

Alzheimers Dement. 2019 Oct 23. pii: S1552-5260(19)35376-2. doi: 10.1016/j.jalz.2019.08.202. [Epub ahead of print]

PMID:
31753701
4.

Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.

Lipton RB, Dodick DW, Ailani J, Lu K, Finnegan M, Szegedi A, Trugman JM.

JAMA. 2019 Nov 19;322(19):1887-1898. doi: 10.1001/jama.2019.16711.

PMID:
31742631
5.

Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials.

Di Tanna GL, Porter JK, Lipton RB, Hatswell AJ, Sapra S, Villa G.

Health Qual Life Outcomes. 2019 Nov 12;17(1):171. doi: 10.1186/s12955-019-1242-6.

6.

Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.

Lipton RB, Fanning KM, Buse DC, Martin VT, Hohaia LB, Adams AM, Reed ML, Goadsby PJ.

Neurology. 2019 Nov 5. pii: 10.1212/WNL.0000000000008589. doi: 10.1212/WNL.0000000000008589. [Epub ahead of print]

PMID:
31690685
7.

Stress is Associated with Neurocognitive Function in Hispanic/Latino Adults: Results from HCHS/SOL Socio-Cultural Ancillary Study.

Muñoz E, Gallo LC, Hua S, Sliwinski M, Kaplan R, Lipton RB, González HM, Penedo FJ, Tarraf W, Daviglus ML, Llabre MM, Isasi CR.

J Gerontol B Psychol Sci Soc Sci. 2019 Nov 2. pii: gbz144. doi: 10.1093/geronb/gbz144. [Epub ahead of print]

PMID:
31677388
8.

Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.

Lipton RB, Munjal S, Brand-Schieber E, Tepper SJ, Dodick DW.

Headache. 2019 Oct 24. doi: 10.1111/head.13663. [Epub ahead of print]

PMID:
31647577
9.

Seizure self-prediction in a randomized controlled trial of stress management.

Privitera M, Haut SR, Lipton RB, McGinley JS, Cornes S.

Neurology. 2019 Nov 26;93(22):e2021-e2031. doi: 10.1212/WNL.0000000000008539. Epub 2019 Oct 23.

PMID:
31645468
10.

Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI.

Sundermann EE, Maki P, Biegon A, Lipton RB, Mielke MM, Machulda M, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2019 Nov 12;93(20):e1881-e1889. doi: 10.1212/WNL.0000000000008467. Epub 2019 Oct 9.

PMID:
31597708
11.

Migraine: Epidemiology, Burden, and Comorbidity.

Burch RC, Buse DC, Lipton RB.

Neurol Clin. 2019 Nov;37(4):631-649. doi: 10.1016/j.ncl.2019.06.001. Epub 2019 Aug 27. Review.

PMID:
31563224
12.

Mentally challenging occupations are associated with more rapid cognitive decline at later stages of cognitive aging.

Hyun J, Katz MJ, Lipton RB, Sliwinski MJ.

J Gerontol B Psychol Sci Soc Sci. 2019 Sep 27. pii: gbz122. doi: 10.1093/geronb/gbz122. [Epub ahead of print]

PMID:
31560775
13.

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.

Rothrock JF, Adams AM, Lipton RB, Silberstein SD, Jo E, Zhao X, Blumenfeld AM; FORWARD Study investigative group.

Headache. 2019 Nov;59(10):1700-1713. doi: 10.1111/head.13653. Epub 2019 Sep 26.

PMID:
31559634
14.

Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.

Seng EK, Singer AB, Metts C, Grinberg AS, Patel ZS, Marzouk M, Rosenberg L, Day M, Minen MT, Lipton RB, Buse DC.

Headache. 2019 Oct;59(9):1448-1467. doi: 10.1111/head.13657. Epub 2019 Sep 26.

PMID:
31557329
15.

Proposed new diagnostic criteria for chronic migraine.

Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J.

Cephalalgia. 2019 Sep 22:333102419877171. doi: 10.1177/0333102419877171. [Epub ahead of print]

PMID:
31544467
16.

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Lipton RB, Hutchinson S, Ailani J, Reed ML, Fanning KM, Manack Adams A, Buse DC.

Headache. 2019 Nov;59(10):1762-1772. doi: 10.1111/head.13642. Epub 2019 Sep 22.

PMID:
31544244
17.

The Independent and Interactive Associations of Bilingualism and Sex on Cognitive Performance in Hispanics/Latinos of the Hispanic Community Health Study/Study of Latinos.

Lamar M, León A, Romo K, Durazo-Arvizu RA, Sachdeva S, Lipton RB, Perreira KM, Gallo LC, Cai J, Khambaty T, Carrasco J, Llabre MM, Eyler LT, Daviglus ML, González HM.

J Alzheimers Dis. 2019;71(4):1271-1283. doi: 10.3233/JAD-190019.

PMID:
31524155
18.

Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer's Disease.

Ezzati A, Zammit AR, Harvey DJ, Habeck C, Hall CB, Lipton RB; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2019;71(3):1027-1036. doi: 10.3233/JAD-190262.

PMID:
31476152
19.

Neuropsychological latent classes at enrollment and postmortem neuropathology.

Zammit AR, Hall CB, Bennett DA, Ezzati A, Katz MJ, Muniz-Terrera G, Lipton RB.

Alzheimers Dement. 2019 Sep;15(9):1195-1207. doi: 10.1016/j.jalz.2019.05.012. Epub 2019 Aug 13.

PMID:
31420203
20.

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujić-Čomić H, Frosch MP, Thonberg H, Maier W, Roshchupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT Jr, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Uitterlinden AGA, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O'Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, Quinn JF, Sacchinelli E, Raj A, Spalletta G, Raskind M, Caltagirone C, Bossù P, Orfei MD, Reisberg B, Clarke R, Reitz C, Smith AD, Ringman JM, Warden D, Roberson ED, Wilcock G, Rogaeva E, Bruni AC, Rosen HJ, Gallo M, Rosenberg RN, Ben-Shlomo Y, Sager MA, Mecocci P, Saykin AJ, Pastor P, Cuccaro ML, Vance JM, Schneider JA, Schneider LS, Slifer S, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tang M, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Saba Y; Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer’s Disease Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE); Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), Pilotto A, Bullido MJ, Peters O, Crane PK, Bennett D, Bosco P, Coto E, Boccardi V, De Jager PL, Lleo A, Warner N, Lopez OL, Ingelsson M, Deloukas P, Cruchaga C, Graff C, Gwilliam R, Fornage M, Goate AM, Sanchez-Juan P, Kehoe PG, Amin N, Ertekin-Taner N, Berr C, Debette S, Love S, Launer LJ, Younkin SG, Dartigues JF, Corcoran C, Ikram MA, Dickson DW, Nicolas G, Campion D, Tschanz J, Schmidt H, Hakonarson H, Clarimon J, Munger R, Schmidt R, Farrer LA, Van Broeckhoven C, O'Donovan MC, DeStefano AL, Jones L, Haines JL, Deleuze JF, Owen MJ, Gudnason V, Mayeux R, Escott-Price V, Psaty BM, Ramirez A, Wang LS, Ruiz A, van Duijn CM, Holmans PA, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Lambert JC, Pericak-Vance MA.

Nat Genet. 2019 Sep;51(9):1423-1424. doi: 10.1038/s41588-019-0495-7.

PMID:
31417202
21.

Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.

Lipton RB, Munjal S, Buse DC, Alam A, Fanning KM, Reed ML, Schwedt TJ, Dodick DW.

Headache. 2019 Sep;59(8):1310-1323. doi: 10.1111/head.13588. Epub 2019 Aug 13.

22.

Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM, Lipton RB.

Headache. 2019 Sep;59(8):1286-1299. doi: 10.1111/head.13613. Epub 2019 Aug 12.

23.

Spotlight on headache.

Lipton RB.

Neurol Clin Pract. 2019 Jun;9(3):182. doi: 10.1212/CPJ.0000000000000679. No abstract available.

PMID:
31342958
24.

Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study.

Lipnicki DM, Makkar SR, Crawford JD, Thalamuthu A, Kochan NA, Lima-Costa MF, Castro-Costa E, Ferri CP, Brayne C, Stephan B, Llibre-Rodriguez JJ, Llibre-Guerra JJ, Valhuerdi-Cepero AJ, Lipton RB, Katz MJ, Derby CA, Ritchie K, Ancelin ML, Carrière I, Scarmeas N, Yannakoulia M, Hadjigeorgiou GM, Lam L, Chan WC, Fung A, Guaita A, Vaccaro R, Davin A, Kim KW, Han JW, Suh SW, Riedel-Heller SG, Roehr S, Pabst A, van Boxtel M, Köhler S, Deckers K, Ganguli M, Jacobsen EP, Hughes TF, Anstey KJ, Cherbuin N, Haan MN, Aiello AE, Dang K, Kumagai S, Chen T, Narazaki K, Ng TP, Gao Q, Nyunt MSZ, Scazufca M, Brodaty H, Numbers K, Trollor JN, Meguro K, Yamaguchi S, Ishii H, Lobo A, Lopez-Anton R, Santabárbara J, Leung Y, Lo JW, Popovic G, Sachdev PS; for Cohort Studies of Memory in an International Consortium (COSMIC).

PLoS Med. 2019 Jul 23;16(7):e1002853. doi: 10.1371/journal.pmed.1002853. eCollection 2019 Jul.

25.

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.

Croop R, Goadsby PJ, Stock DA, Conway CM, Forshaw M, Stock EG, Coric V, Lipton RB.

Lancet. 2019 Aug 31;394(10200):737-745. doi: 10.1016/S0140-6736(19)31606-X. Epub 2019 Jul 13.

PMID:
31311674
26.

Migraine Progression: A Systematic Review. An Editorial Comment.

Buse DC, Greisman JD, Baigi K, Lipton RB.

Headache. 2019 Jul;59(7):974-976. doi: 10.1111/head.13573. No abstract available.

PMID:
31297806
27.

Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.

Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, Dubowchik GM, Conway CM, Coric V, Goadsby PJ.

N Engl J Med. 2019 Jul 11;381(2):142-149. doi: 10.1056/NEJMoa1811090.

PMID:
31291516
28.

Assessing diagnostic error in cerebral venous thrombosis via detailed chart review.

Liberman AL, Bakradze E, Mchugh DC, Esenwa CC, Lipton RB.

Diagnosis (Berl). 2019 Nov 26;6(4):361-367. doi: 10.1515/dx-2019-0003.

PMID:
31271550
29.

Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.

Ford JH, Ayer DW, Zhang Q, Carter JN, Leroux E, Skljarevski V, Aurora SK, Tockhorn-Heidenreich A, Lipton RB.

Neurology. 2019 Jul 30;93(5):e508-e517. doi: 10.1212/WNL.0000000000007856. Epub 2019 Jul 3.

30.

Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraine.

Farris SG, Thomas JG, Abrantes AM, Lipton RB, Burr EK, Godley FA, Roth JL, Pavlovic JM, Bond DS.

Cephalalgia. 2019 Oct;39(11):1465-1469. doi: 10.1177/0333102419861712. Epub 2019 Jul 1.

PMID:
31260336
31.

A Birth Cohort Analysis of Amnestic Mild Cognitive Impairment Incidence in the Einstein Aging Study (EAS) Cohort.

Derby CA, Katz MJ, Rozner S, Lipton RB, Hall CB.

J Alzheimers Dis. 2019;70(s1):S271-S281. doi: 10.3233/JAD-181141.

32.

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.

Dodick DW, Lipton RB, Silberstein S, Goadsby PJ, Biondi D, Hirman J, Cady R, Smith J.

Cephalalgia. 2019 Aug;39(9):1075-1085. doi: 10.1177/0333102419858355. Epub 2019 Jun 24.

PMID:
31234642
33.

A coordinated multi-study analysis of the longitudinal association between handgrip strength and cognitive function in older adults.

Zammit AR, Piccinin AM, Duggan EC, Koval A, Clouston S, Robitaille A, Brown CL, Handschuh P, Wu C, Jarry V, Finkel D, Graham RB, Muniz-Terrera G, Björk MP, Bennett D, Deeg DJ, Johansson B, Katz MJ, Kaye J, Lipton RB, Martin M, Pederson NL, Spiro A, Zimprich D, Hofer SM.

J Gerontol B Psychol Sci Soc Sci. 2019 Jun 11. pii: gbz072. doi: 10.1093/geronb/gbz072. [Epub ahead of print]

PMID:
31187137
34.

Pathophysiology, prevention, and treatment of medication overuse headache.

Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB, Porreca F, Silberstein S, Schwedt T.

Lancet Neurol. 2019 Sep;18(9):891-902. doi: 10.1016/S1474-4422(19)30146-2. Epub 2019 Jun 4. Review.

PMID:
31174999
35.

Anxiety Sensitivity as a Risk Indicator for Anxiety, Depression, and Headache Severity in Women With Migraine.

Farris SG, Burr EK, Abrantes AM, Thomas JG, Godley FA, Roth JL, Lipton RB, Pavlovic JM, Bond DS.

Headache. 2019 Sep;59(8):1212-1220. doi: 10.1111/head.13568. Epub 2019 Jun 5.

PMID:
31166015
36.

Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study.

Verghese J, Wang C, Bennett DA, Lipton RB, Katz MJ, Ayers E.

Alzheimers Dement. 2019 Jul;15(7):870-877. doi: 10.1016/j.jalz.2019.03.011. Epub 2019 Jun 1.

PMID:
31164315
37.

Health-related Quality of Life, Cognitive Performance, and Incident Dementia in a Community-based Elderly Cohort.

Ezzati A, Zammit AR, Katz MJ, Derby CA, Zimmerman ME, Lipton RB.

Alzheimer Dis Assoc Disord. 2019 Jul-Sep;33(3):240-245. doi: 10.1097/WAD.0000000000000324.

PMID:
31135451
38.

The relationship between hippocampal volume, chronic pain, and depressive symptoms in older adults.

Ezzati A, Zammit AR, Lipton ML, Lipton RB.

Psychiatry Res Neuroimaging. 2019 Jul 30;289:10-12. doi: 10.1016/j.pscychresns.2019.05.003. Epub 2019 May 15.

PMID:
31112826
39.

Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.

Dodick DW, Silberstein SD, Lipton RB, DeGryse RE, Adams AM, Diener HC.

Cephalalgia. 2019 Jul;39(8):945-956. doi: 10.1177/0333102418825382. Epub 2019 May 21.

PMID:
31112399
40.

Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.

Ezzati A, Zammit AR, Habeck C, Hall CB, Lipton RB; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2019 May 18. doi: 10.1007/s11682-019-00115-6. [Epub ahead of print]

PMID:
31104279
41.

Timing of onset and rate of decline in learning and retention in the pre-dementia phase of Alzheimer's disease.

Grober E, An Y, Lipton RB, Kawas C, Resnick SM.

J Int Neuropsychol Soc. 2019 Aug;25(7):699-705. doi: 10.1017/S1355617719000304.

PMID:
31094304
42.

Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized Trial.

McGinley JS, Buse DC, Shulman KJ, Wirth RJ, Hugentobler E, Lipton RB.

Headache. 2019 Jul;59(7):1002-1013. doi: 10.1111/head.13530. Epub 2019 May 7.

PMID:
31062349
43.

Cardiovascular disease risk factor burden and cognition: Implications of ethnic diversity within the Hispanic Community Health Study/Study of Latinos.

Lamar M, Durazo-Arvizu RA, Sachdeva S, Pirzada A, Perreira KM, Rundek T, Gallo LC, Grober E, DeCarli C, Lipton RB, Tarraf W, González HM, Daviglus ML.

PLoS One. 2019 Apr 22;14(4):e0215378. doi: 10.1371/journal.pone.0215378. eCollection 2019.

44.

Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.

Lipton RB, Tepper SJ, Reuter U, Silberstein S, Stewart WF, Nilsen J, Leonardi DK, Desai P, Cheng S, Mikol DD, Lenz R.

Neurology. 2019 May 7;92(19):e2250-e2260. doi: 10.1212/WNL.0000000000007452. Epub 2019 Apr 17.

45.

Naproxen for presymptomatic Alzheimer disease: Is this the end, or shall we try again?

Hershey LA, Lipton RB.

Neurology. 2019 Apr 30;92(18):829-830. doi: 10.1212/WNL.0000000000007233. Epub 2019 Apr 5. No abstract available.

PMID:
30952790
46.

Relationship Between Treatment Initiation and Healthcare Costs in Alzheimer's Disease.

Black CM, Lipton RB, Thiel E, Brouillette M, Khandker R.

J Alzheimers Dis. 2019;68(4):1575-1585. doi: 10.3233/JAD-180983.

PMID:
30909221
48.

Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.

Speck RM, Shalhoub H, Wyrwich KW, Yu R, Ayer DW, Ford J, Bush EN, Lipton RB.

Headache. 2019 May;59(5):756-774. doi: 10.1111/head.13497. Epub 2019 Mar 12.

49.

Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.

Pavlovic JM, Yu JS, Silberstein SD, Reed ML, Kawahara SH, Cowan RP, Dabbous F, Campbell KL, Shewale AR, Pulicharam R, Kowalski JW, Viswanathan HN, Lipton RB.

Cephalalgia. 2019 Apr;39(4):465-476. doi: 10.1177/0333102418825373. Epub 2019 Mar 9.

50.

A Multi-study Coordinated Meta-analysis of Pulmonary Function and Cognition in Aging.

Duggan EC, Piccinin AM, Clouston S, Koval AV, Robitaille A, Zammit AR, Wu C, Brown CL, Lee LO, Finkel D, Beasley WH, Kaye J, Terrera GM, Katz M, Lipton RB, Deeg D, Bennett DA, Praetorius Björk M, Johansson B, Spiro A, Weuve J, Hofer SM.

J Gerontol A Biol Sci Med Sci. 2019 Oct 4;74(11):1793-1804. doi: 10.1093/gerona/glz057.

PMID:
30825374

Supplemental Content

Loading ...
Support Center